Table 2.
Correlation analysis.
| Variables | EP2 IRS score | EP2 percentage score | ||
|---|---|---|---|---|
| p Value | Correlation coefficient | p Value | Correlation coefficient | |
| pT | 0.81 | −0.015 | 0.648 | −0.029 |
| pN | 0.917 | −0.007 | 0.601 | −0.033 |
| pM | 0.212 | −0.079 | 0.199 | −0.082 |
| Histotype | 0.3 | −0.066 | 0.328 | −0.062 |
| Grading | 0.561 | 0.037 | 0.524 | 0.041 |
| FIGO | 0.369 | −0.057 | 0.287 | −0.068 |
| EP3 | <0.01* | 0.232 | <0.01* | 0.278 |
| galectin−3 | 0.06 | 0.121 | 0.016* | 0.154 |
| E6 | 0.843 | −0.013 | 0.989 | −0.001 |
| p16 | 0.184 | −0.087 | 0.062 | −0.122 |
| p53 | 0.348 | 0.06 | 0.408 | 0.053 |
| MDM2 | 0.852 | 0.012 | 0.776 | 0.018 |
| GPER | 0.817 | 0.015 | 0.36 | 0.058 |
pT, tumor status; pN, lymph node status, pM, metastasis status, FIGO, the International Federation of Gynecology and Obstetrics; GPER, G protein-coupled estrogen receptor.